Redesign Health
PrivateLast Round
Venture Fund
Dec 12, 2024
Est. Valuation
$1.7B
Total Funding Raised
$165M
Company Overview
Redesign Health is a venture builder and venture capital firm that focuses on creating and scaling transformative healthcare companies. Founded in 2018, the company's mission is to power innovation in the healthcare industry by providing founders with the necessary tools, resources, and expertise. Redesign Health's model involves ideating new company concepts, developing them, and then launching them with a dedicated leadership team. The firm has a broad focus within healthcare, targeting areas such as the healthcare labor shortage, value-based care, health equity, and the application of AI. Since its inception, Redesign Health has launched over 60 companies that have collectively impacted more than 15 million patients and generated over $1 billion in revenue. The company operates as both a builder of new enterprises and an investor, managing funds to fuel the creation of these healthcare startups.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Patient Engagement
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Redesign Health Comps
Public and private peers based on sector, stage, and business model.
Redesign Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Venture Fund | Dec 12, 2024 | ||||
| Series C | Sep 13, 2022 | ||||
| Series B | Mar 25, 2021 | ||||
| VC Round | Mar 25, 2021 |
Redesign Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Aetna Ventures | Series C |
| TriplePoint Capital | Series C |
| General Catalyst | Series C |
| Samsung Next TLV | Series C |
| Eden Global Associates | Series C |
| CVS Health Ventures | Series C |
| Declaration Partners | Series C, VC Round, Series B, Venture Fund |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Launched Digital Innovation Platform with Cedars-Sinai.
- Apr 24, 2026
Portfolio companies have impacted over 15 million patients since 2018.
Redesign Health Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Redesign Health's valuation, stock price, and market status.
